4.5 Article

Rational Design, Optimization, and Biological Evaluation of Novel MEK4 Inhibitors against Pancreatic Adenocarcinoma

期刊

ACS MEDICINAL CHEMISTRY LETTERS
卷 12, 期 10, 页码 1559-1567

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acsmedchemlett.1c00376

关键词

mitogen-activated protein kinases; drug discovery; small molecule inhibitors; lead optimization; pancreatic cancer

资金

  1. Lurie Research Innovation Challenge Award
  2. NIH [T32GM105538, F31CA250353]
  3. NIH/NCI [T32CA070085]
  4. Northwestern Undergraduate Research Grant
  5. Soft and Hybrid Nanotechnology Experiment (SHyNE) Resource [NSF ECCS-2025633]
  6. [R01CA217907]
  7. [R21CA255291]

向作者/读者索取更多资源

The study presents two potent MEK4 inhibitors which showed significant reduction in phospho-JNK and antiproliferative properties against pancreatic cancer cell lines. Additionally, molecular inhibition of the MEK4 pathway activates the MEK1/2 pathway, with the combination of MEK1/2 and MEK4 inhibitors demonstrating synergistic effects against pancreatic cancer cells. These inhibitors provide insight into the crosstalk between MAPK pathways and new tools for elucidating the roles of MEK4 in disease states.
Growth, division, and development of healthy cells relies on efficient response to environmental survival cues. The conserved mitogen-activated protein kinase (MAPK) family of pathways interface extracellular stimuli to intracellular processes for this purpose. Within these pathways, the MEK family has been identified as a target of interest due to its clinical relevance. Particularly, MEK4 has drawn recent attention for its indications in pancreatic and prostate cancers. Here, we report two potent MEK4 inhibitors demonstrating significant reduction of phospho-JNK and antiproliferative properties against pancreatic cancer cell lines. Furthermore, molecular inhibition of MEK4 pathway activates the MEK1/2 pathway, with the combination of MEK1/2 and MEK4 inhibitors demonstrating synergistic effects against pancreatic cancer cells. Our inhibitors provided insight into the crosstalk between MAPK pathways and new tools for elucidating the roles of MEK4 in disease states, findings which will pave the way for better understanding of the MAPK pathways and development of additional probes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据